Home›Companies›InverseBio

InverseBio Inc.

Active
No website or LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Apr 16, 2026·Suggest an edit

About InverseBio

InverseBio is a private company based in Cambridge, Massachusetts, incorporated in 2026 in Delaware. It has reported $500,000 raised in one offering on Form D since April 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 1, 2026Apr 16, 2026$500,000of $600K target1$500KOptions, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on InverseBio's Form D filed Apr 16, 2026.

LP
Lawrence Phillips
President and director

Sources

  1. SECInverseBio Inc. filing history